Vanguard Health Care ETF (VHT)
163.07
+0.54 +0.33%
NYSE Arca
Jun 19, 20:00
Delayed 2m
USD
VHT Key Stats
| Net Asset Value | Upgrade |
| Discount or Premium to NAV | Upgrade |
| Turnover Ratio | Upgrade |
View All VHT News
VHT News
-
WireHeadlineTime (ET)
-
MT Newswires06/20 09:18
-
Business Wire06/20 08:05
-
MT Newswires06/19 13:25
-
MT Newswires06/19 09:17
-
MT Newswires06/18 13:18
-
MT Newswires06/18 09:09
-
MT Newswires06/15 13:27
-
MT Newswires06/15 09:18
-
MT Newswires06/14 13:19
-
MT Newswires06/14 09:19
VHT Performance
| Total Return (Price) | Total Return (NAV) | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|---|
| 1M | 3.03% | 3.01% | 3.30% | 61 |
| 3M | 2.87% | 2.92% | 3.39% | 72 |
| 6M | 5.08% | 5.13% | 10.30% | 68 |
| YTD | 6.05% | 6.09% | 10.03% | 61 |
| 1Y | 12.85% | 12.87% | 19.71% | 58 |
| 3Y | 6.19% | 6.20% | 4.09% | 25 |
| 5Y | 14.80% | 14.82% | 14.55% | 46 |
| 10Y | 13.57% | 13.56% | 13.86% | 56 |
VHT Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 1.25% | 1.25% | 0.00% |
| Stock | 98.74% | 98.74% | 0.00% |
| Bond | 0.00% | 0.00% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.00% | 0.00% | 0.00% |
| Other | 0.01% | 0.01% | 0.00% |
VHT Region Exposure
| Americas | 99.81% |
| North America | 99.79% |
| Latin America | 0.02% |
| Greater Europe | 0.18% |
| United Kingdom | 0.12% |
| Europe Developed | 0.06% |
| Europe Emerging | 0.00% |
| Africa/Middle East | 0.00% |
| Greater Asia | 0.01% |
| Japan | 0.00% |
| Australasia | 0.00% |
| Asia Developed | 0.01% |
| Asia Emerging | 0.00% |
| Market Classification | |
| % Developed Markets | 100.0% |
| % Emerging Markets | 0.00% |
VHT Stock Sector Exposure
| Basic Materials | 0.00% |
| Communication Services | 0.00% |
| Consumer Cyclical | 0.00% |
| Consumer Defensive | 0.00% |
| Energy | 0.00% |
| Financial Services | 0.04% |
| Healthcare | 98.37% |
| Industrials | 0.06% |
| Real Estate | 0.00% |
| Technology | 1.53% |
| Utilities | 0.00% |
VHT Stock Market Capitalization
| Giant | 46.94% |
| Large | 33.10% |
| Medium | 13.70% |
| Small | 5.66% |
| Micro | 0.61% |
VHT Stock Style Exposure
| Large Cap Value | 29.85% |
| Large Cap Blend | 24.59% |
| Large Cap Growth | 25.85% |
| Mid Cap Value | 1.22% |
| Mid Cap Blend | 3.22% |
| Mid Cap Growth | 9.28% |
| Small Cap Value | 0.52% |
| Small Cap Blend | 1.64% |
| Small Cap Growth | 3.83% |
View More Holdings
As of May 31, 2018
VHT Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 8.38% | 122.37 | -0.16% |
| UNH | UnitedHealth Group Inc | 6.11% | 252.35 | -0.26% |
| PFE | Pfizer Inc | 5.59% | 36.22 | +0.00% |
| MRK | Merck & Co Inc | 4.19% | 60.98 | -0.08% |
| ABBV | AbbVie Inc | 4.10% | 98.10 | +0.09% |
| AMGN | Amgen Inc | 3.16% | 185.00 | -0.64% |
| MDT | Medtronic PLC | 3.06% | 86.39 | -0.25% |
| ABT | Abbott Laboratories | 2.81% | 62.30 | -0.06% |
| GILD | Gilead Sciences Inc | 2.31% | 70.75 | -0.27% |
| BMY | Bristol-Myers Squibb Company | 2.24% | 53.64 | +0.00% |
Advertisement
VHT One Page Reports
- One Page Report Download
VHT Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Blend |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Vanguard |
| Benchmark Index | |
|---|---|
MSCI US IMI/Health Care 25-50 GR USD |
100.0% |
VHT Manager Info
| Name | Tenure |
|---|---|
| Michelle Louie | 0.00 yrs |
| Walter Nejman | 1.94 yrs |
VHT Net Fund Flows
| 1M | -36.15M |
| 3M | -76.27M |
| 6M | -138.15M |
| YTD | -83.19M |
| 1Y | 309.72M |
| 3Y | 943.69M |
| 5Y | 3.789B |
| 10Y | 4.553B |
VHT Risk Info
| Beta (5Y) | 0.9287 |
| Max Drawdown (All) | 39.01% |
| Historical Sharpe (10Y) | 0.9216 |
| Historical Sortino (All) | 0.9151 |
| 30-Day Rolling Volatility | 11.12% |
| Daily Value at Risk (VaR) 1% (All) | 2.90% |
| Monthly Value at Risk (VaR) 1% (All) | 12.86% |
VHT Fundamentals
| Dividend Yield TTM (6-19-18) | 1.21% |
| SEC Yield (6-18-18) | 1.46% |
| Weighted Average PE Ratio | 26.13 |
| Weighted Average Price to Sales Ratio | 1.765 |
| Weighted Average Price to Book Ratio | 3.867 |
| Weighted Median ROE | 13.79% |
| Weighted Median ROA | 3.46% |
| Forecasted Dividend Yield | 1.54% |
| Forecasted PE Ratio | 15.88 |
| Forecasted Price to Sales Ratio | 1.656 |
| Forecasted Price to Book Ratio | 3.491 |
| Number of Holdings | 380 |
VHT Growth Estimates
| Forecasted 5 Yr Earnings Growth | 11.22% |
| Forecasted Book Value Growth | 6.43% |
| Forecasted Cash Flow Growth | 7.18% |
| Forecasted Earnings Growth | -0.96% |
| Forecasted Revenue Growth | 8.63% |
VHT Attributes
| Key Dates | |
|---|---|
| Inception Date | 1/26/2004 |
| Termination Date | |
| Last Annual Report Date | 8/31/2017 |
| Last Prospectus Date | 12/21/2017 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
VHT Excel Add-In Codes
- Name: =YCI("VHT","name")
- Broad Asset Class: =YCI("VHT", "broad_asset_class")
- Broad Category: =YCI("VHT", "broad_category_group")
- Prospectus Objective: =YCI("VHT", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
